- Home
- ADAP vs DIBS Comparison
ADAP vs DIBS Comparison
Compare ADAP & DIBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- DIBS
- Stock Information
- Founded
- ADAP 2008
- DIBS 2000
- Country
- ADAP United Kingdom
- DIBS United States
- Employees
- ADAP N/A
- DIBS N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- DIBS Catalog/Specialty Distribution
- Sector
- ADAP Health Care
- DIBS Consumer Discretionary
- Exchange
- ADAP Nasdaq
- DIBS Nasdaq
- Market Cap
- ADAP 75.5M
- DIBS 88.1M
- IPO Year
- ADAP 2015
- DIBS 2021
- Fundamental
- Price
- ADAP $0.28
- DIBS $2.48
- Analyst Decision
- ADAP Buy
- DIBS Hold
- Analyst Count
- ADAP 6
- DIBS 1
- Target Price
- ADAP $1.52
- DIBS N/A
- AVG Volume (30 Days)
- ADAP 1.6M
- DIBS 134.6K
- Earning Date
- ADAP 05-13-2025
- DIBS 05-09-2025
- Dividend Yield
- ADAP N/A
- DIBS N/A
- EPS Growth
- ADAP N/A
- DIBS N/A
- EPS
- ADAP N/A
- DIBS N/A
- Revenue
- ADAP $179,639,000.00
- DIBS $88,740,000.00
- Revenue This Year
- ADAP N/A
- DIBS $3.23
- Revenue Next Year
- ADAP $52.49
- DIBS $5.90
- P/E Ratio
- ADAP N/A
- DIBS N/A
- Revenue Growth
- ADAP 878.53
- DIBS 4.93
- 52 Week Low
- ADAP $0.20
- DIBS $2.30
- 52 Week High
- ADAP $1.48
- DIBS $5.80
- Technical
- Relative Strength Index (RSI)
- ADAP 49.68
- DIBS 46.83
- Support Level
- ADAP $0.26
- DIBS $2.39
- Resistance Level
- ADAP $0.30
- DIBS $2.56
- Average True Range (ATR)
- ADAP 0.03
- DIBS 0.14
- MACD
- ADAP 0.00
- DIBS 0.01
- Stochastic Oscillator
- ADAP 54.53
- DIBS 40.00
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The Company has a single reportable and operating segment that contains one reporting unit, which consists of the Company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.